Literature DB >> 4325096

Infectious complications of neoplastic disease.

D Armstrong, L S Young, R D Meyer, A H Blevins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4325096     DOI： 10.1016/s0025-7125(16)32514-7

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN： 0025-7125            Impact factor:   5.456


× No keyword cloud information.
  26 in total

1.  Enhanced toxicity for mice of combinations of bacterial lipopolysaccharide and vincristine.

Authors:  A E Munson; D C Drummond; A C Adams; S G Bradley
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

2.  Unexplained falciparum malaria in a patient with chronic lymphocytic leukemia.

Authors:  R Duperval; B Longpré; P Madarnas
Journal:  Can Med Assoc J       Date:  1979-12-22       Impact factor: 8.262

3.  Editorial: Fever in malignant disease.

Authors: 
Journal:  Br Med J       Date:  1974-03-30

4.  Studies on detection of Candida antigen in the sera of mice inoculated orally with Candida albicans.

Authors:  H Suzuki; H Taguchi; K Nishimura; M Miyaji; A Nakamura; H Nakajima
Journal:  Mycopathologia       Date:  1988-10       Impact factor: 2.574

5.  Double beta-lactam regimen compared to an aminoglycoside/beta-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.

Authors:  J H Joshi; K A Newman; B W Brown; R S Finley; R L Ruxer; M A Moody; S C Schimpff
Journal:  Support Care Cancer       Date:  1993-07       Impact factor: 3.603

6.  Depression of contact sensitivity and enhancement of antibody response in Pseudomonas aeruginosa-infected mice.

Authors:  M Campa; C Garzelli; G Falcone
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

7.  Septicemia in children with leukemia.

Authors:  Y DeClerck; D DeClerck; G E Rivard; P Benoit
Journal:  Can Med Assoc J       Date:  1978-06-24       Impact factor: 8.262

8.  Febrile neutropenia in French emergency departments: results of a prospective multicentre survey.

Authors:  Stéphanie André; Pierre Taboulet; Caroline Elie; Noël Milpied; Michel Nahon; Gérald Kierzek; Mariève Billemont; Franck Perruche; Sandrine Charpentier; Hélène Clément; Jean-Louis Pourriat; Yann-Erick Claessens
Journal:  Crit Care       Date:  2010-04-19       Impact factor: 9.097

9.  Virus-specific antibodies in sera from patients with genital herpes simplex virus infection.

Authors:  H J Zweerink; L Corey
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

10.  Tobramycin (nebramycin factor 6): in vitro activity against Pseudomonas aeruginosa.

Authors:  R D Meyer; L S Young; D Armstrong
Journal:  Appl Microbiol       Date:  1971-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.